Skip to main content

AgeX Therapeutics, Inc. (AGE)

NYSEAMERICAN: AGE · IEX Real-Time Price · USD
0.905 0.002 (0.21%)
Oct 25, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year20202019201820172016
Revenue
1.871.731.41.41.67
Revenue Growth
8.10%23.78%-0.57%-15.73%-
Cost of Revenue
0.160.240.360.170.3
Gross Profit
1.711.481.031.241.36
Selling, General & Admin
7.48.145.653.875.62
Research & Development
4.985.95.835.788.48
Other Operating Expenses
000.8-1.750
Operating Expenses
12.3814.0412.287.914.1
Operating Income
-10.67-12.56-11.25-6.66-12.74
Interest Expense / Income
0.5-0.0300.010.03
Other Expense / Income
-0.16-0.52-3.74-0.12.73
Pretax Income
-11.02-12.01-7.5-6.58-15.49
Income Tax
-0.150.15000
Net Income
-10.87-12.15-7.5-6.58-15.49
Net Income Common
-10.87-12.15-7.5-6.58-15.49
Shares Outstanding (Basic)
3837353129
Shares Outstanding (Diluted)
3837353129
Shares Change
1.07%6.75%13.93%6.40%-
EPS (Basic)
-0.29-0.33-0.21-0.21-0.54
EPS (Diluted)
-0.29-0.33-0.21-0.21-0.54
Free Cash Flow Per Share
-0.21-0.29-0.23-0.20-0.29
Gross Margin
91.54%85.88%73.93%88.03%81.75%
Operating Margin
-571.25%-726.79%-805.52%-474.57%-764.65%
Profit Margin
-581.64%-703.36%-537.39%-468.66%-929.89%
Free Cash Flow Margin
-419.54%-625.06%-574.21%-447.72%-507.20%
Effective Tax Rate
1.36%-1.23%0.00%0.00%0.00%
EBITDA
-8.83-11.08-6.97-5.89-14.62
EBITDA Margin
-472.91%-641.44%-499.07%-419.23%-877.67%
EBIT
-10.52-12.04-7.5-6.57-15.47
EBIT Margin
-562.96%-696.47%-537.39%-467.81%-928.39%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).